Apurinic/apyrimidinic endonuclease-1 is associated with angiogenesis and VEGF production via upregulation of COX-2 expression in esophageal cancer tissues

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 306, Issue 3, 2014, Pages

  Nagoya, Hiroyuki ^a   Futagami, Seiji ^a   Shimpuku, Mayumi ^a   Tatsuguchi, Atsushi ^a   Wakabayashi, Taiga ^a   Yamawaki, Hiroshi ^a   Kodaka, Yasuhiro ^a   Kawagoe, Tetsuro ^a   Watarai, Yasuhiko ^a   Makino, Hiroshi ^a   Miyashita, Masao ^a   Tsuchiya, Shinichi ^a   Crowe, Sheila E ^b   Sakamoto, Choitsu ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

Apurinic apyrimidinic endonuclease 1; Cyclooxygenase 2; Esophageal cancer; Monocyte chemoattractant protein 1; Vascular endothelial growth factor

Indexed keywords

CHEMOKINE RECEPTOR CCR2; CISPLATIN; CYCLOOXYGENASE 2; DNA (APURINIC OR APYRIMIDINIC SITE) LYASE; DNA (APURINIC OR APYRIMIDINIC SITE) LYASE 1; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; SMALL INTERFERING RNA; STAT3 PROTEIN; UNCLASSIFIED DRUG; VASCULOTROPIN;

ADULT; AGED; ANGIOGENESIS; APOPTOSIS; ARTICLE; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION; VERY ELDERLY; WESTERN BLOTTING;

APURINIC/APYRIMIDINIC ENDONUCLEASE-1; CYCLOOXYGENASE-2; ESOPHAGEAL CANCER; MONOCYTE CHEMOATTRACTANT PROTEIN-1; VASCULAR ENDOTHELIAL GROWTH FACTOR;

AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CHEMOKINE CCL2; CYCLOOXYGENASE 2; DNA REPAIR; DNA-(APURINIC OR APYRIMIDINIC SITE) LYASE; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84893427797     PISSN: 01931857     EISSN: 15221547     Source Type: Journal    
DOI: 10.1152/ajpgi.00057.2013     Document Type: Article

References (37)

1. Bhakat K, Mantha A, Mitra S. Transcriptional regulatory functions of mammalian AP-endonuclease (APE1/Ref-1), an essential multifunctional protein. Antioxid Redox Signal 11: 621-638, 2009.
2. Bhattacharyya A, Chattopadhyay R, Burnette BR, Cross JV, Mitra S, Ernst PB, Bhakat KK, Crowe SE. Acetylation of apurinic/apyrimidinic endonuclease-1 regulates Helicobacter pylori-mediated gastric epithelial cell apoptosis. Gastroenterology 136: 2258-2269, 2009.
3. Bobola MS, Finn LS, Ellenbogen RG, Geyer JR, Berger MS, Braga JM, Meade EH, Gross ME, Silber JR. Apurinic/apyrimidinic endonuclease activity is associated with response to radiation and chemotherapy in medulloblastoma and primitive neuroectodermal tumors. Clin Cancer Res 11: 7405-7414, 2005.
4. Chen M, Cai E, Huang J, Yu P, Li K. Prognostic value of vascular endothelial growth factor expression in patients with esophageal cancer: a systematic review and meta-analysis. Cancer Epidemiol Biomarkers Prev 21: 1126-1134, 2012.
5. Dempke W, Rie C, Grothey A, Schmoll HJ. Cyclooxygenase-2: a novel target for cancer chemotherapy? J Cancer Res Clin Oncol 127: 411-417, 2001.
6. Di Maso V, Avellini C, Crocè LS, Rosso N, Quadrifoglio F, Cesaratto L, Codarin E, Bedogni G, Beltrami CA, Tell G, Tiribelli C. Subcellular localization of APE1/Ref-1 in human hepatocellular carcinoma: possible prognostic significance. Mol Med 13: 89-96, 2007.
7. Fung H, Demple B. A vital role for Ape1/Ref1 protein in repairing spontaneous DNA damage in human cells. Mol Cell 17: 463-470, 2005.
8. Futagami S, Kawagoe T, Horie A, Shindo T, Hamamoto T, Suzuki K, Kusunoki M, Miyake K, Gudis K, Tsukui T, Crowe SE, Sakamoto C. Celecoxib inhibits apurinic/apyrimidinic endonuclease-1 expression and prevents gastric cancer in Helicobacter pylori-infected Mongolian gerbils. Digestion 78: 93-102, 2008.
9. Futagami S, Hiratsuka T, Shindo T, Horie A, Hamamoto T, Suzuki K, Kusunoki M, Miyake K, Gudis K, Crowe SE, Tsukui T, Sakamoto C. Expression of apurinic/apyrimidinic endonuclease-1 (APE-1) in H. pyloriassociated gastritis, gastric adenoma, and gastric cancer. Helicobacter 13: 209-218, 2008.
10. Gray MJ, Zhang J, Ellis LM, Semenza GL, Evans DB, Watowich SS, Gallick GE. HIF-1alpha, STAT3, CBP/p300 and Ref-1/APE are components of a transcriptional complex that regulates Src-dependent hypoxiainduced expression of VEGF in pancreatic and prostate carcinomas. Oncogene 24: 3110-3120, 2005.
11. Hall JL, Wang X, Van Adamson Zhao Y, Gibbons GH. Overexpression of Ref-1 inhibits hypoxia and tumor necrosis factor-induced endothelial cell apoptosis through nuclear factor-kappab-independent and-dependent pathways. Circ Res 88: 1247-1253, 2001.
12. Hansen WK, Deutsch WA, Yacoub A, Xu Y, Williams DA, Kelley MR. Creation of a fully functional human chimeric DNA repair protein. Combining O6-methylguanine DNA methyltransferase (MGMT) and AP endonuclease (APE/redox effector factor 1 (Ref 1) DNA repair proteins. J Biol Chem 273: 756-762, 1998.
13. Husvik C, Bryne M, Halstensen TS. Epidermal growth factor-induced cyclooxygenase-2 expression in oral squamous cell carcinoma cell lines is mediated through extracellular signal-regulated kinase 1/2 and p38 but is Src and nuclear factor-kappa B independent. Eur J Oral Sci 117: 528-535, 2009.
14. Jiang A, Gao H, Kelley MR, Qiao X. Inhibition of APE1/Ref-1 redox activity with APX3330 blocks retinal angiogenesis in vitro and in vivo. Vision Res 51: 93-100, 2011.
15. Jiang Y, Zhou S, Sandusky GE, Kelley MR, Fishel ML. Reduced expression of DNA repair and redox signaling protein APE1/Ref-1 impairs human pancreatic cancer cell survival, proliferation, and cell cycle progression. Cancer Invest 28: 885-895, 2010.
16. Kakolyris S, Kaklamanis L, Engels K, Turley H, Hickson ID, Gatter KC, Harris AL. Human apurinic endonuclease 1 expression in a colorectal adenoma-carcinoma sequence. Cancer Res 57: 1794-1797, 1997.
17. Kitadai Y, Haruma K, Tokutomi T, Tanaka S, Sumii K, Carvalho M, Kuwabara M, Yoshida K, Hirai T, Kajiyama G, Tahara E. Significance of vessel count and vascular endothelial growth factor in human esophageal carcinomas. Clin Cancer Res 4: 2195-2200, 1998.
18. Koukourakis MI, Giatromanolaki A, Kakolyris S, Sivridis E, Georgoulias V, Funtzilas G, Hickson ID, Gatter KC, Harris AL. Nuclear expression of human apurinic/apyrimidinic endonuclease (HAP1/Ref-1) in headand-neck cancer is associated with resistance to chemoradiotherapy and poor outcome. Int J Radiat Oncol Biol Phys 50: 27-36, 2001.
19. Lau JP, Weatherdon KL, Skalski V, Hedley DW. Effects of gemcitabine on APE/ref-1 endonuclease activity in pancreatic cancer cells, and the therapeutic potential of antisense oligonucleotides. Br J Cancer 91: 1166-1173, 2004.
20. Loeb LA, Preston BD. Mutagenesis by apurinic/apyrimidinic sites. Annu Rev Genet 20: 201-230, 1986.
21. Luo M, Delaplane S, Jiang A, Reed A, He Y, Fishel M, Nyland RL 2nd, Borch RF, Qiao X, Georgiadis MM, Kelley MR. Role of the multifunctional DNA repair and redox signaling protein Ape1/Ref-1 in cancer and endothelial cells: small-molecule inhibition of the redox function of Ape1. Antioxid Redox Signal 10: 1853-1867, 2008.
22. Mrena J, Wiksten JP, Thiel A, Kokkola A, Pohjola L, Lundin J, Nordling S, Ristimäki A, Haglund C. Cyclooxygenase-2 is an independent prognostic factor in gastric cancer and its expression is regulated by the messenger RNA stability factor HuR. Clin Cancer Res 11: 7362-7368, 2005.
23. Ochoa O, Sun D, Reys-Reyna SM, Waite LL, Michalek JE, McManus LM, Shireman PK. Delayed angiogenesis and VEGF production in CCR2+/+ mice during impaired skeletal muscle regeneration. Am J Physiol Regul Integr Comp Physiol 293: R651-R661, 2007.
24. Ohta M, Kitadai Y, Tanaka S, Yoshihara M, Yasui W, Mukaida N, Haruma K, Chayama K. Monocyte chemoattractant protein-1 expression correlates with macrophage infiltration and tumor vascularity in human esophageal squamous cell carcinomas. Int J Cancer 102: 220-224, 2002.
25. Ono Y, Furuta T, Ohmoto T, Akiyama K, Seki S. Stable expression in rat glioma cells of sense and antisense nucleic acids to a human multifunctional DNA repair enzyme, APEX nuclease. Mutat Res 315: 55-63, 1994.
26. Salcedo R, Ponce ML, Young HA, Wasserman K, Ward JM, Kleinman HK, Oppenheim JJ, Murphy WJ. Human endothelial cells express CCR2 and respond to MCP-1: direct role of MCP-1 in angiogenesis and tumor progression. Blood 96: 34-40, 2000.
27. Silber JR, Bobola MS, Blank A, Schoeler KD, Haroldson PD, Huynh MB, Kolstoe DD. The apurinic/apyrimidinic endonuclease activity of Ape1/Ref-1 contributes to human glioma cell resistance to alkylating agents and is elevated by oxidative stress. Clin Cancer Res 8: 3008-3018, 2002.
28. Song J, Futagami S, Nagoya H, Kawagoe T, Yamawaki H, Kodaka Y, Tatsuguchi A, Gudis K, Wakabayashi T, Yonazawa M, Shimpuku M, Watarai Y, Iwakiri K, Hoshihara Y, Makino H, Miyashita M, Tsuchiya S, Li Y, Crowe SE, Sakamoto C. Apurinic/apyrimidinic endonuclease-1 (APE-1) is overexpressed via the activation of NF-kB-p65 in MCP-1-positive esophageal squamous cell carcinoma tissue. J Clin Biochem Nutr 52: 112-119, 2013.
29. Toomey DP, Murphy JF, Conlon KC. COX-2, VEGF and tumour angiogenesis. Surgeon 7: 174-180, 2009.
30. Walker LJ, Craig RB, Harris AL, Hickson ID. A role for the human DNA repair enzyme HAP1 in cellular protection against DNA damaging agents and hypoxic stress. Nucleic Acids Res 22: 4884-4889, 1994.
31. Wang D, Dubois RN. Prostaglandins and cancer. Gut 55: 115-122, 2005.
32. Wang D, Luo M, Kelley MR. Human apurinic endonuclease 1 (APE1) expression and prognostic significance in osteosarcoma: enhanced sensitivity of osteosarcoma to DNA damaging agents using silencing RNA APE1 expression inhibition. Mol Cancer Ther 3: 679-686, 2004.
33. Wang D, Xiang DB, Yang XQ, Chen LS, Li MX, Zhong ZY, Zhang YS. APE1 overexpression is associated with cisplatin resistance in nonsmall cell lung cancer and targeted inhibition of APE1 enhances the activity of cisplatin in A549 cells. Lung Cancer 66: 298-304, 2009.
34. Wu WK, Sung JJ, Lee CW, Yu J, Cho CH. Cyclooxygenase-2 in tumorigenesis of gastrointestinal cancers: an update on the molecular mechanisms. Cancer Lett 295: 7-16, 2010.
35. Ziel KA, Campbell CC, Wilson GL, Gillespie MN. Ref-1/Ape is critical for formation of the hypoxia-inducible transcriptional complex on the hypoxic response element of the rat pulmonary artery endothelial cell VEGF gene. FASEB J 18: 986-988, 2004.
36. Zimmermann KC, Sarbia M, Weber AA, Borchard F, Gabbert HE, Schrör K. Cyclooxygenase-2 expression in human esophageal carcinoma. Cancer Res 59: 198-204, 1999.
37. Zou GM, Karikari C, Kabe Y, Handa H, Anders RA, Maitra A. The Ape-1/Ref-1 redox antagonist E3330 inhibits the growth of tumor endothelium and endothelial progenitor cells: therapeutic implications in tumor angiogenesis. J Cell Physiol 219: 209-218, 2009.